Close Menu

NEW YORK – Bionano Genomics has filed regulatory documents for a public offering of up to $30 million of its common stock and warrants to purchase its common stock.

The genome mapping firm also amended its loan agreement with Innovatus Life Science Lending Fund on March 6 and will make prepayments on the principal totaling $5 million and pay fees of $300,000. Moreover, Bionano registered a resale of approximately 1.1. million shares of its common stock on behalf of Innovatus.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.